vs

Side-by-side financial comparison of APTARGROUP, INC. (ATR) and Noble Corp plc (NE). Click either name above to swap in a different company.

APTARGROUP, INC. is the larger business by last-quarter revenue ($962.7M vs $764.4M, roughly 1.3× Noble Corp plc). Noble Corp plc runs the higher net margin — 11.3% vs 7.7%, a 3.6% gap on every dollar of revenue. On growth, APTARGROUP, INC. posted the faster year-over-year revenue change (13.5% vs -17.6%). APTARGROUP, INC. produced more free cash flow last quarter ($96.9M vs $35.4M). Over the past eight quarters, Noble Corp plc's revenue compounded faster (9.5% CAGR vs 2.6%).

AptarGroup, Inc., also known as Aptar, is a United States–based global manufacturer of consumer dispensing packaging and drug delivery devices. The group has manufacturing operations in 18 countries.

Barnes & Noble Booksellers is an American bookseller with the largest number of retail outlets in the United States. The company operates approximately 700+ retail stores across the United States.

ATR vs NE — Head-to-Head

Bigger by revenue
ATR
ATR
1.3× larger
ATR
$962.7M
$764.4M
NE
Growing faster (revenue YoY)
ATR
ATR
+31.1% gap
ATR
13.5%
-17.6%
NE
Higher net margin
NE
NE
3.6% more per $
NE
11.3%
7.7%
ATR
More free cash flow
ATR
ATR
$61.5M more FCF
ATR
$96.9M
$35.4M
NE
Faster 2-yr revenue CAGR
NE
NE
Annualised
NE
9.5%
2.6%
ATR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ATR
ATR
NE
NE
Revenue
$962.7M
$764.4M
Net Profit
$74.3M
$86.6M
Gross Margin
Operating Margin
11.0%
5.6%
Net Margin
7.7%
11.3%
Revenue YoY
13.5%
-17.6%
Net Profit YoY
-26.4%
-10.4%
EPS (diluted)
$1.13
$0.54

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ATR
ATR
NE
NE
Q4 25
$962.7M
$764.4M
Q3 25
$961.1M
$798.0M
Q2 25
$966.0M
$848.7M
Q1 25
$887.3M
$874.5M
Q4 24
$848.1M
$927.3M
Q3 24
$909.3M
$800.5M
Q2 24
$910.1M
$692.8M
Q1 24
$915.4M
$637.1M
Net Profit
ATR
ATR
NE
NE
Q4 25
$74.3M
$86.6M
Q3 25
$127.9M
$-21.1M
Q2 25
$111.7M
$42.9M
Q1 25
$78.8M
$108.3M
Q4 24
$100.9M
$96.6M
Q3 24
$100.0M
$61.2M
Q2 24
$90.5M
$195.0M
Q1 24
$83.1M
$95.5M
Operating Margin
ATR
ATR
NE
NE
Q4 25
11.0%
5.6%
Q3 25
14.2%
6.3%
Q2 25
14.9%
15.9%
Q1 25
12.8%
21.4%
Q4 24
14.2%
18.4%
Q3 24
15.2%
14.4%
Q2 24
13.8%
30.3%
Q1 24
12.2%
16.9%
Net Margin
ATR
ATR
NE
NE
Q4 25
7.7%
11.3%
Q3 25
13.3%
-2.6%
Q2 25
11.6%
5.1%
Q1 25
8.9%
12.4%
Q4 24
11.9%
10.4%
Q3 24
11.0%
7.6%
Q2 24
9.9%
28.1%
Q1 24
9.1%
15.0%
EPS (diluted)
ATR
ATR
NE
NE
Q4 25
$1.13
$0.54
Q3 25
$1.92
$-0.13
Q2 25
$1.67
$0.27
Q1 25
$1.17
$0.67
Q4 24
$1.48
$0.56
Q3 24
$1.48
$0.40
Q2 24
$1.34
$1.34
Q1 24
$1.23
$0.66

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ATR
ATR
NE
NE
Cash + ST InvestmentsLiquidity on hand
$409.5M
$471.4M
Total DebtLower is stronger
$1.1B
Stockholders' EquityBook value
$2.7B
$4.5B
Total Assets
$5.3B
$7.5B
Debt / EquityLower = less leverage
0.43×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ATR
ATR
NE
NE
Q4 25
$409.5M
$471.4M
Q3 25
$264.8M
$477.9M
Q2 25
$169.8M
$338.2M
Q1 25
$136.8M
$303.8M
Q4 24
$226.2M
$247.3M
Q3 24
$327.9M
$391.9M
Q2 24
$223.9M
$162.9M
Q1 24
$201.1M
$212.5M
Total Debt
ATR
ATR
NE
NE
Q4 25
$1.1B
Q3 25
$546.0M
Q2 25
$535.1M
Q1 25
$561.2M
Q4 24
$688.1M
Q3 24
$822.7M
Q2 24
$681.5M
Q1 24
$680.4M
Stockholders' Equity
ATR
ATR
NE
NE
Q4 25
$2.7B
$4.5B
Q3 25
$2.8B
$4.5B
Q2 25
$2.7B
$4.6B
Q1 25
$2.5B
$4.7B
Q4 24
$2.5B
$4.7B
Q3 24
$2.5B
$4.7B
Q2 24
$2.4B
$4.0B
Q1 24
$2.3B
$3.9B
Total Assets
ATR
ATR
NE
NE
Q4 25
$5.3B
$7.5B
Q3 25
$5.1B
$7.6B
Q2 25
$4.9B
$7.7B
Q1 25
$4.5B
$7.9B
Q4 24
$4.4B
$8.0B
Q3 24
$4.6B
$8.0B
Q2 24
$4.5B
$5.6B
Q1 24
$4.4B
$5.4B
Debt / Equity
ATR
ATR
NE
NE
Q4 25
0.43×
Q3 25
0.20×
Q2 25
0.20×
Q1 25
0.22×
Q4 24
0.28×
Q3 24
0.32×
Q2 24
0.28×
Q1 24
0.29×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ATR
ATR
NE
NE
Operating Cash FlowLast quarter
$183.7M
$187.1M
Free Cash FlowOCF − Capex
$96.9M
$35.4M
FCF MarginFCF / Revenue
10.1%
4.6%
Capex IntensityCapex / Revenue
9.0%
19.9%
Cash ConversionOCF / Net Profit
2.47×
2.16×
TTM Free Cash FlowTrailing 4 quarters
$299.6M
$432.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ATR
ATR
NE
NE
Q4 25
$183.7M
$187.1M
Q3 25
$177.6M
$277.1M
Q2 25
$126.0M
$216.4M
Q1 25
$82.7M
$271.1M
Q4 24
$178.2M
$136.2M
Q3 24
$229.3M
$283.8M
Q2 24
$143.6M
$106.8M
Q1 24
$92.3M
$128.7M
Free Cash Flow
ATR
ATR
NE
NE
Q4 25
$96.9M
$35.4M
Q3 25
$114.3M
$139.5M
Q2 25
$62.5M
$99.8M
Q1 25
$25.9M
$157.5M
Q4 24
$112.2M
$-4.4M
Q3 24
$162.7M
$156.8M
Q2 24
$75.4M
$-34.3M
Q1 24
$16.7M
$-37.9M
FCF Margin
ATR
ATR
NE
NE
Q4 25
10.1%
4.6%
Q3 25
11.9%
17.5%
Q2 25
6.5%
11.8%
Q1 25
2.9%
18.0%
Q4 24
13.2%
-0.5%
Q3 24
17.9%
19.6%
Q2 24
8.3%
-4.9%
Q1 24
1.8%
-6.0%
Capex Intensity
ATR
ATR
NE
NE
Q4 25
9.0%
19.9%
Q3 25
6.6%
17.3%
Q2 25
6.6%
13.7%
Q1 25
6.4%
13.0%
Q4 24
7.8%
15.2%
Q3 24
7.3%
15.9%
Q2 24
7.5%
20.4%
Q1 24
8.3%
26.2%
Cash Conversion
ATR
ATR
NE
NE
Q4 25
2.47×
2.16×
Q3 25
1.39×
Q2 25
1.13×
5.05×
Q1 25
1.05×
2.50×
Q4 24
1.77×
1.41×
Q3 24
2.29×
4.64×
Q2 24
1.59×
0.55×
Q1 24
1.11×
1.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ATR
ATR

Pharma Segment$833.1M87%
Other$129.6M13%

NE
NE

Floaters$559.8M73%
Jackups$145.5M19%
Service Other$59.1M8%

Related Comparisons